Evidence map›Paper›PMID 39917507›Full record

ArticleIndian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion2025

Antifungal Prophylaxis and Treatment of Breakthrough Invasive Fungal Diseases in High-Risk Hematology Patients: A Prospective Observational Multicenter Study.

Gökhan Metan, Ayşe Çiftçioğlu, Rabin Saba, Ayşegül Ulu Kılıç, Kevser Özdemir, Yasemin Çağ, Demet Kiper Ünal, Firdevs Aksoy, Hande Berk, Gürkan Mert and 15 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Antifungal Management in Patients with Hematological Malignancies: From Primary Prophylaxis to Empirical and Diagnosis-Driven TreatmentTurkish journal of haematology : official journal of Turkish Society of Haematology · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Gökhan MetanDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe Üniversitesi Tıp Fakültesi Hastanesi, İç Hastalıkları Binası, Enfeksiyon Hastalıkları Ve Klinik Mikrobiyoloji Anabilim Dalı, Sıhhıye, Ankara, Türkiye.
Ayşe ÇiftçioğluClinical Research Unit, Faculty of Medicine, Ankara University, Ankara, Türkiye.
Rabin SabaInfectious Diseases Clinic, Medstar Hospital, Antalya, Türkiye.
Ayşegül Ulu KılıçDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Erciyes University, Kayseri, Türkiye.
Kevser ÖzdemirDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Pamukkale University, Denizli, Türkiye.
Yasemin ÇağDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Medeniyet University, Istanbul, Türkiye.
Demet Kiper ÜnalDepartment of Hematology, Faculty of Medicine, Ege University, İzmir, Türkiye.
Firdevs AksoyDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Türkiye.
Hande BerkDepartment of Infectious Diseases and Clinical Microbiology, Antalya Research and Education Hospital, Medical Sciences University, Antalya, Türkiye.
Gürkan MertDepartment of Infectious Diseases and Clinical Microbiology, Gülhane Medical Academy, Ankara, Türkiye.
Özlem Güzel TunçcanDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Gazi University, Ankara, Türkiye.
Anıl TombakDepartment of Hematology, Faculty of Medicine, Mersin University, Mersin, Türkiye.
İlker İnanç BalkanDepartment of Infectious Diseases and Clinical Microbiology, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul, Türkiye.
Sema Alp ÇavuşDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Dokuz Eylül University, İzmir, Türkiye.
Bahar KandemirDepartment of Infectious Diseases and Clinical Microbiology, Necmettin Erbakan University, Konya, Türkiye.
Birsen MutluDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Kocaeli University, Kocaeli, Türkiye.
Ahmet Çağkan İnkayaDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe Üniversitesi Tıp Fakültesi Hastanesi, İç Hastalıkları Binası, Enfeksiyon Hastalıkları Ve Klinik Mikrobiyoloji Anabilim Dalı, Sıhhıye, Ankara, Türkiye.
Leylagül KaynarDepartment of Hematology, Faculty of Medicine, Erciyes University, Kayseri, Türkiye.
Memiş Hilmi AtayDepartment of Hematology, Faculty of Medicine, 19 Mayıs University, Samsun, Türkiye.
Fadime Ersoy DursunDepartment of Hematology, Faculty of Medicine, Medeniyet University, Istanbul, Türkiye.
Güray SaydamDepartment of Hematology, Faculty of Medicine, Ege University, İzmir, Türkiye.
Yakup ÜnsalHematology Clinic, Emsey Hospital, Istanbul, Türkiye.
Simge Fidan SarıDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Kocaeli University, Kocaeli, Türkiye.
Hamdi AkanClinical Research Unit, Faculty of Medicine, Ankara University, Ankara, Türkiye.
Study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to investigate the approaches for antifungal prophylaxis (AFP) and antifungal treatment in breakthrough invasive fungal diseases (IFDs) under AFP in high-risk hematology patients. Patients ≥ 18-years who received chemotherapy for acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL) or a conditioning regimen for allogeneic hematopoietic stem cell transplantation (AHSCT) with a duration of neutropenia (< 500 cells/mm

Indexed as

Acute leukemiaAntifungal prophylaxisAntifungal treatmentBreakthrough invasive fungal diseasesFluconazolePosaconazoleStem cell transplantation

Identifiers

PMID39917507
PMCPMC11794909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.